Gupteswar Logo

upteswar

Gujarat Inject Reports Strong H1 FY27 Results, Approves Solar Project and Preferential Issue

BusinessManasi Praharaj11 Nov 2026

Vadodara, November 11, 2026 Gujarat Inject (Kerala) Limited (BSE: 524238), a trading and renewable energy enterprise, today announced its unaudited standalone financial results for the second quarter (Q2) and half-year (H1) ended September 30, 2026.

Financial Highlights (Standalone)

Half-Year Ended September 30, 2026 (H1 FY27 vs H1 FY26):

●     Total Revenue from Operations: Reached ₹1,827.43 Lakhs, compared to ₹399.75 Lakhs in H1 FY26.

●     Profit Before Tax (PBT): Rose to ₹264.18 Lakhs, up from ₹18.82 Lakhs in the corresponding prior-year period.

●     Net Profit After Tax (PAT): Stood at ₹197.69 Lakhs, compared to ₹14.10 Lakhs in H1 FY26.

●     Earnings Per Share (EPS): Basic and Diluted EPS stood at ₹0.13 per share (restated post 1:10 stock split), compared to ₹0.01 per share in H1 FY26.

Quarter Ended September 30, 2026 (Q2 FY27):

●     Total Revenue from Operations: Reported at ₹581.98 Lakhs (comprising ₹482.17 Lakhs from Trading and ₹99.81 Lakhs from Solar Power Generation).

●     Profit Before Tax (PBT): Stood at ₹95.42 Lakhs.

●     Net Profit After Tax (PAT): Reported at ₹72.53 Lakhs.

Key Strategic & Operational Updates

  1. Commercialization of Solar Power Project: The Company officially capitalized its Solar Power Generation Plant from Capital Work in Progress (CWIP) into Property, Plant & Equipment during Q2 FY27. Revenue flow commenced in line with Ind-AS 115 principles, contributing ₹99.81 Lakhs in revenue and ₹89.68 Lakhs in segment profit before tax during the quarter.
  2. Equity Share Sub-Division (Stock Split 1:10): During the period, the face value of the Company’s equity shares was sub-divided/split from ₹10 each into 10 Equity Shares of ₹1 each (record date: July 08, 2026). Prior period EPS figures have been restated accordingly to maintain comparability.
  3. Proposed Fund Raising & Increase in Authorised Capital: To fuel strategic expansion and meet capital needs, the Board of Directors approved:

○     Increasing the Authorised Share Capital from ₹15,00,00,000 to ₹17,63,48,000.

○     Raising funds up to ₹3,00,00,000 (Rupees Three Crores) through the issuance of 3,00,00,000 Equity Warrants (face value ₹1 each) on a preferential basis to non-promoter/public category investors, subject to shareholder and regulatory approvals.

Management Statement

Commenting on the results, Mr. Murli Shivshankaran Nair, Managing Director of Gujarat Inject (Kerala) Limited, stated: "The first half of FY27 marks a transformational phase for our organization. The successful operationalization and capitalization of our Solar Power Generation segment diversifies our business profile and brings long-term, high-margin revenue visibility alongside our core trading activities. The proposed preferential issue and corporate structural adjustments further strengthen our capital structure as we pursue sustainable, long-term growth for our shareholders."